medical cannabis

Akanda Plans First Shipment of Medical Cannabis to Germany and Anticipates Leading Market Share Position

September 26th, 2022 - Ryan Allway

Akanda prepares first export shipment to Germany of high THC indoor cultivated premium cannabis from its Portugal-based Holigen operation in the coming weeks Akanda aims to capture approximately 10% market share German medical cannabis imports based on recent data   LONDON–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) expects […]

Canonic Launches its Second-Generation Medical Cannabis Products with High THC and Unique Terpene Profiles

September 21st, 2022 - Ryan Allway

The new and improved products are derived from novel proprietary cannabis varieties developed using genetic markers utilizing Evogene’s GeneRator AI tech-engine   REHOVOT, Israel, Sept. 21, 2022 /PRNewswire/ — Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. ( Nasdaq: EVGN, TASE: EVGN), today announced the launch of its second-generation products in Israel. […]

Akanda Bolsters Leadership Team to Scale Medical Cannabis Platform Across Europe

August 24th, 2022 - Ryan Allway

Tom Flow Named Chief Operating Officer and Steven George Named Commercial Director   LONDON, August 24, 2022–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced that it has appointed Tom Flow to the role of Chief Operating Officer of Akanda and Managing Director of Holigen, and Steven George […]

Khiron Completes Acquisition of Pharmadrug Production GmbH, Establishing German Pharmaceutical Distribution Capabilities

August 2nd, 2022 - Ryan Allway

Acquisition provides Khiron with an EU-GMP European manufacturing and distribution hub for medical cannabis and other pharmaceutical products The acquisition of Pharmadrug Production GmbH provides Khiron with direct access to German pharmacies and increase in gross margins for its products With acquisition completed, Khiron will continue sales of its current products and expand its portfolio, […]

WEED Inc. (USA) Acquires Hempirical Genetics LLC, w/Over 250 Proprietary Cannabis & Hemp Strains for $750,000.00

July 20th, 2022 - Ryan Allway

HEMP BioSciences Inc., a wholly-owned Division of WEED Inc will oversee our Genetics Programs. Panama Red, Acapulco Gold, Red Bud Colombian & Santa Marta Gold top the list.   TUCSON, AZ / ACCESSWIRE / July 20, 2022 / WEED, Inc. (OTCQB:BUDZ) (“WEED” or the “Company”) a global cannabis & hemp bioresearch company based in the USA, […]

Texas Original Opens Drive-Thru Medical Cannabis Pickup Location in Waco, Texas

June 28th, 2022 - Ryan Allway

AUSTIN, Texas, June 28, 2022–(BUSINESS WIRE)–Texas Original, Texas’ leading medical cannabis provider, announced its newest prescription pickup location has opened in Waco, Texas. The new location is Waco’s first medical cannabis pickup site and the first drive-thru location in the state. The pickup location is open every Friday between 10:30 a.m. and 2 p.m. for […]

Akanda’s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK

June 28th, 2022 - Ryan Allway

LONDON–(BUSINESS WIRE)-June 28, 2022-Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and distribution wholly-owned subsidiary CanMart Ltd. (“CanMart”) has partnered with Phlo Connect and Cellen Life Sciences (“Cellen”) to create a first-of-its-kind fully digital dispensing collaboration for medical cannabis. The strategic partnership strengthens […]

Khiron Life Sciences Reports 2021 Fiscal Year End Results

May 2nd, 2022 - Ryan Allway

2021 total revenue increased over 60% YoY to $12.8 million compared to the previous year Corporation’s medical cannabis sales in 2021 increased to $4.6 million, representing 36% of total revenue The Corporation forecasts Q1 2022 sales revenue of ~ $4.5 million for the quarter Gross profit increased over 230% YoY to $4.9 million, driven by the continuous growth of the highly […]

Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access

April 20th, 2022 - Ryan Allway

Transformational deal will add prized cultivation, manufacturing and distribution assets to accelerate Akanda’s seed-to-patient model and satisfy demand in fast-growing European cannabis markets Akanda will have immediate EU GMP certification, a significantly expanded product portfolio, and an award-winning genetics library   LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today […]

Global Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in Colombia

April 11th, 2022 - Ryan Allway

Continues market leadership in Colombia, Latin America’s only country with universal health coverage for medical cannabis   Market leader in the Colombian medical cannabis market, with Q1 2022 volume sales exceeding 21,400 units, up 280% YoY and more than 40% of all 2021 New clinic continues Khiron’s unique patient acquisition and retention strategy, adding more than 20% of patient capacity to existing network Located in […]

Unity Rd. Partners Awarded Medical Cannabis Establishment Registration Certificate in South Dakota

April 11th, 2022 - Ryan Allway

Local Partners Kick Off Development with Groundbreaking for One of the First Establishments in Hartford; Cannabis Dispensary Franchise Now Developing in 10-Plus U.S. Markets   SIOUX FALLS, S.D., April 11, 2022 /PRNewswire/ — Unity Rd., the national cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), announced today that the brand’s first partners in South Dakota have received approval from Hartford, a suburb […]

NUGL Inc. Closes Acquisition Of Kaya LLC, One Of Jamaica’s Leading, Vertically Integrated Medical Cannabis Companies

April 5th, 2022 - Ryan Allway

The combined companies will showcase strong leadership teams, a portfolio of powerful brands and operations delivering quality at scale   The new combined company will utilize multiple markets, retail locations, technologies and distribution facilities, paired with solid backing and options to operate in numerous countries   LOS ANGELES and KINGSTON, Jamaica, April 05, 2022 (GLOBE […]

Franchise Global Health Inc. Announces First Day of Trading & Market Opening

March 29th, 2022 - Ryan Allway

VANCOUVER, BC / ACCESSWIRE / March 29, 2022 / Franchise Global Health Inc. (“Franchise Global” or the “Company”) (TSXV: FGH) is pleased to announce that the Company’s shares will commence trading at market open today on the TSX Venture Exchange under the symbol “FGH”. In addition, Clifford Starke, Executive Chairman and CEO of Franchise Global and his team […]

AUDACIOUS Opens Medical Cannabis Clinic in Southeast Asia, Expanding Global Footprint into Thai Medical Cannabis Market

March 21st, 2022 - Ryan Allway

AUDACIOUS is the first US Multi-State Operator to open a cannabis clinic in Thailand in partnership with Thai-based Golden Triangle Health.   LAS VEGAS, March 21, 2022 /PRNewswire/ – Just as the dynamic Thai medical cannabis market begins to blossom, AUDACIOUS and Thai-based partner Golden Triangle Health have partnered to open the first Herbidus Medical Center in Bangkok, which is also the first medical […]

UCASU to partner with seasoned cannabis growers for $50 million cannabis portfolio

March 21st, 2022 - Ryan Allway

Atlanta, March 21, 2022 (GLOBE NEWSWIRE) — UC Asset LP (OTCQX: UCASU) announces the company is launching a program to form investor-grower partnerships with seasoned cannabis growers, who are licensed in their own states to grow hemp, medical cannabis or recreational cannabis plants, to work on UC Asset’s cannabis portfolio properties that are expected to […]

IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results

March 10th, 2022 - Ryan Allway

Q4 2021 revenues expected to be at least $20 million, an increase of at least 308% year-over-year and at least 37% sequentially   Full Year 2021 revenues expected to increase at least 240% year-over-year to at least $54 million   TORONTO and GLIL YAM, Israel, March 10, 2022 /PRNewswire/ — IM Cannabis Corp. (the “Company“, “IM Cannabis“, or “IMC”) (CSE: IMCC) (NASDAQ: IMCC), […]

Village Farms International Announces Pure Sunfarms’ Receipt of EU GMP Certification

March 9th, 2022 - Ryan Allway

– EU GMP Certification Permits Pure Sunfarms to Export Cannabis Products to EU Medical Markets – First Shipments Targeted for Third Quarter 2022 –   VANCOUVER, BC, March 9, 2022 /PRNewswire/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced its wholly owned subsidiary, Pure Sunfarms, has received EU GMP certification from Bezirksregierung […]

Curaleaf Expands Pennsylvania Retail Presence with Dispensary Openings in State College and Erie

February 18th, 2022 - Ryan Allway

Newest Dispensaries Expand Company’s Retail Presence to 16 Locations in Fast Growing Pennsylvania Medical Market, and 127 Nationwide   WAKEFIELD, Mass., Feb. 18, 2022 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced the opening of its State College dispensary, located at 1248 S Atherton […]

Khiron Adds Another Clinic Location in Peru

February 17th, 2022 - Ryan Allway

Khiron partners with specialized pain clinic, Clínica del Dolor Lima (“CDL”) to provide medical cannabis treatment access to its over 10,000 chronic pain patient population   TORONTO, Feb. 17, 2022 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global medical cannabis leader with core operations in Latin America and Europe, is pleased to […]

Dr. Reddy’s Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbH

February 3rd, 2022 - Ryan Allway

FRANKFURT, Germany & HYDERABAD, India, February 03, 2022–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a definitive agreement to acquire Nimbus Health GmbH (“Nimbus Health”). Nimbus Health is a privately owned, licensed pharmaceutical […]

RYAH Closes Initial Tranche of Private Placement Units

January 27th, 2022 - Ryan Allway

TORONTO, ON / ACCESSWIRE / January 27, 2022 / RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company“) is pleased to provide an update to its previously announced non-brokered private placement of units of the Company (“Units“) for aggregate gross proceeds of up to C$1,500,000, at an issue price of C$0.05 per Unit (the “Private Placement“). As […]

Panaxia and Neuraxpharm: First export of medical cannabis sublingual tablets to France

January 24th, 2022 - Ryan Allway

The first-of-its-kind export is part of the companies’ participation in the French government’s program to regulate the medical cannabis industry   Both companies have previously issued their premium oils to patients in France   DÜSSELDORF, Germany and TEL AVIV, Israel, Jan. 24, 2022 /PRNewswire/ — Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX), a global pharma company which develops, manufactures and markets […]

OTC Markets Group Welcomes Mystic Holdings Inc. to OTCQX

January 21st, 2022 - Ryan Allway

NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Mystic Holdings Inc. (OTCQX: MSTH), a company focused on cannabis cultivation, production and retail, has qualified to trade on the OTCQX® Best Market. Mystic Holdings Inc. upgraded to OTCQX from the Pink® […]

Hebrew University and TechforCann Europe Accelerator to Collaborate on Funding Medical Cannabis Research Companies Worldwide

January 14th, 2022 - Ryan Allway

JERUSALEM, ISRAEL… January 14, 2022 — The Hebrew University of Jerusalem’s (HU) Technology Transfer Company, Yissum, together with the TechforCann Europe Accelerator, announces a strategic collaboration with TechforCann, Europe’s first medical cannabis tech accelerator, to fund startups around the world.   Researchers at HU’s Multidisciplinary Center for Cannabinoid Research, (MCCR) will serve as advisory board members, mentors, and potential candidates for the startups that are accepted into the TechforCann Europe Accelerator program. The HU Medical Cannabis online curriculum will also be available to international audiences through the […]

Stem Holdings Reports Fiscal Full Year 2021 Financial Results

January 13th, 2022 - Ryan Allway

BOCA RATON, Fla., Jan. 13, 2022 (GLOBE NEWSWIRE) — Stem Holdings, Inc. (OTCQX: STMH) (CSE: STEM) (the “Company” or “Stem”), a vertically integrated cannabis operator, today reported its financial results for the fiscal year ended September 30, 2021. All amounts are expressed in U.S. dollars unless indicated otherwise and are prepared under International Financial Reporting Standards […]

HTC to Sell $5 Million in Hemp Extraction Assets to, and Receive Option to Acquire Equity Interest in, Starling Brands Inc.

January 7th, 2022 - Ryan Allway

Regina, Saskatchewan – TheNewswire – January 7, 2022 – HTC Purenergy Inc. o/a HTC Extraction Systems (“HTC” or the “Company”) (TSXV:HTC), (OTCQB:HTPRF), (UII:FRA) today announced that further to its news release dated December 31, 2021, it has applied for approval from the TSX Venture Exchange (the “TSXV”) of its sale (the “Transaction”) of certain of its assets used in its California-based […]

Save Foods Enters into Distribution Agreement with Cannabis Producer BRLEV AGRICULTURAL CROPS LTD. to Address Contamination in Cannabis Products

January 6th, 2022 - Ryan Allway

Microbial contamination projected to cost cannabis industry $3 billion Tel Aviv, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) — Save Foods (NASDAQ: SVFD) (“Save Foods” or the “Company”), an Israeli Agri-Food Tech company announced today a distribution agreement with Israeli cannabis company BRLEV AGRICULTURAL CROPS LTD. (“BRLev”) to provide Save Foods’ eco crop protection treatment as a white […]

Instadose Pharma Corp Ships 2.125 Metric Tons – Largest International Cannabis Delivery in History

January 5th, 2022 - Ryan Allway

Instadose Pharma Corp delivers 2.125 Metric Tons of Medicinal Cannabis from South Africa to North Macedonia in a historic international delivery, this record-breaking shipment represents the largest Cannabis shipment globally to date.   CHESAPEAKE, Va., Jan. 5, 2022 /PRNewswire/ – (OTC PINK: INSD) Instadose Pharma Corp (the “company” or “Instadose”) Establishing the world largest continual supply of Medicinal Cannabis. Instadose Pharma […]

MPX International’s Thailand Subsidiary Establishes First State-Of-The-Art, High-Capacity Cannabis/Hemp Manufacturing and Extraction Laboratory in Asia in Response to Surging Demand for CBD and Thc Products

January 5th, 2022 - Ryan Allway

TORONTO, ONTARIO – TheNewswire – January 4, 2022 – MPX International Corporation (“MPX International”, “MPXI” or the “Corporation”) (CSE:MPXI) (CNSX:MPXI.CN) (OTC:MPXOF), a multinational diversified cannabis company, and its subsidiary, Salus International Management Ltd. (“SIM”), a management company currently focused on operations in Southeast Asia, are pleased to announce that Salus Bioceutical (Thailand) Co. Ltd. (“SBT”), in partnership with SIM, is opening a 600-million-baht (C$22,900,000) cannabis/hemp production plant (the “Facility”) […]

Mandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 million Colombians

January 4th, 2022 - Ryan Allway

Starting January 1st, 2022, every insurance provider in Colombia, is now mandated to cover the costs of high and low THC medical cannabis prescriptions   Significantly improves the current insurance coverage process, simplifying the procedure and reducing approval times for patients to obtain insurance coverage across the country   Colombia has upwards of 6 million potential patients for medical cannabis […]

Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at,, or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at and You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit:

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer